Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivax misoprostol ANDA approved

Executive Summary

Ivax is shipping generic versions of Pharmacia's Cytotec (misoprostol) tablets in 100 mcg and 200 mcg strengths following July 10 approval. Cytotec's patent expired July 29, 2000. Misoprostol is used for prevention of NSAID-induced gastric ulcers and is also part of the two-drug abortifacient regimen with Danco's Mifeprex (mifepristone, RU-486)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS040155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel